Search research articles
Contact Us
Filters
Showing results (811-820 of 929) with videos related to
Page
of 93
Sort By:
Cancer Research
|
July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history
T R Rebbeck, Y Wang, P W Kantoff, et al.
JAMA Oncology
|
May 1, 2018
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
Joanne Kotsopoulos, Jacek Gronwald, Beth Y Karlan, et al.
Annals of Family Medicine
|
November 10, 2010
Field test results of a new ambulatory care Medication Error and Adverse Drug Event Reporting System--MEADERS
John Hickner, Atif Zafar, Grace M Kuo, et al.
Diseases of the Colon and Rectum
|
September 12, 2007
Hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Argentina: report from a referral hospital register
Carlos A Vaccaro, Fernando Bonadeo, Analía V Roverano, et al.
Cancer Research
|
April 3, 2008
Origins and prevalence of the American Founder Mutation of MSH2
Mark Clendenning, Mark E Baze, Shuying Sun, et al.
Human Molecular Genetics
|
April 30, 2003
FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome
Benjamin M Kriederman, Teressa L Myloyde, Marlys H Witte, et al.
Breast Cancer Research and Treatment
|
February 6, 2013
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
Steven A Narod, Kelly Metcalfe, Henry T Lynch, et al.
Gynecologic Oncology
|
May 26, 2018
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
Joanne Kotsopoulos, Jacek Gronwald, Beth Karlan, et al.
Cancer Research
|
December 3, 2005
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats
David E Blask, George C Brainard, Robert T Dauchy, et al.
Neurology
|
May 29, 2003
Parkin-proven disease: common founders but divergent phenotypes
S Lincoln, J Wiley, T Lynch, et al.
Page
of 93
Search research articles
Search
Showing results (811-820 of 929) with videos related to
Sort By:
Page
of 93
Cancer Research
|
July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history
T R Rebbeck, Y Wang, P W Kantoff, et al.
JAMA Oncology
|
May 1, 2018
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
Joanne Kotsopoulos, Jacek Gronwald, Beth Y Karlan, et al.
Annals of Family Medicine
|
November 10, 2010
Field test results of a new ambulatory care Medication Error and Adverse Drug Event Reporting System--MEADERS
John Hickner, Atif Zafar, Grace M Kuo, et al.
Diseases of the Colon and Rectum
|
September 12, 2007
Hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Argentina: report from a referral hospital register
Carlos A Vaccaro, Fernando Bonadeo, Analía V Roverano, et al.
Cancer Research
|
April 3, 2008
Origins and prevalence of the American Founder Mutation of MSH2
Mark Clendenning, Mark E Baze, Shuying Sun, et al.
Human Molecular Genetics
|
April 30, 2003
FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome
Benjamin M Kriederman, Teressa L Myloyde, Marlys H Witte, et al.
Breast Cancer Research and Treatment
|
February 6, 2013
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
Steven A Narod, Kelly Metcalfe, Henry T Lynch, et al.
Gynecologic Oncology
|
May 26, 2018
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
Joanne Kotsopoulos, Jacek Gronwald, Beth Karlan, et al.
Cancer Research
|
December 3, 2005
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats
David E Blask, George C Brainard, Robert T Dauchy, et al.
Neurology
|
May 29, 2003
Parkin-proven disease: common founders but divergent phenotypes
S Lincoln, J Wiley, T Lynch, et al.
Page
of 93